August Bioservices

August Bioservices, a pharmaceutical manufacturing and support services company that recently announced big growth plans for its Nashville-based headquarters, has closed a $23.6 million round of funding.

The Series A extension round was led by investment firm Polaris Partners, which joined existing investor Oak HC/FT. The funds will go toward expanding August’s manufacturing capacity and enhancing its technology to support new production lines, according to a press release.